vs
GULFPORT ENERGY CORP(GPOR)与Ultragenyx Pharmaceutical Inc.(RARE)财务数据对比。点击上方公司名可切换其他公司
GULFPORT ENERGY CORP的季度营收约是Ultragenyx Pharmaceutical Inc.的1.9倍($398.2M vs $207.3M),GULFPORT ENERGY CORP净利率更高(33.3% vs -62.0%,领先95.3%),GULFPORT ENERGY CORP同比增速更快(66.0% vs 25.9%),过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高(38.0% vs 18.6%)
Gulfport Energy Corp是一家总部位于美国的独立油气勘探生产企业,核心运营区域覆盖俄亥俄州尤蒂卡页岩区、俄克拉荷马州SCOOP产区,主要生产天然气、原油及天然气液,供应北美工业、公用事业及商业终端市场。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业,专注于研发罕见病和超罕见遗传病的创新治疗方案,这类疾病目前大多无获批疗法,存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台,研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GPOR vs RARE — 直观对比
营收规模更大
GPOR
是对方的1.9倍
$207.3M
营收增速更快
GPOR
高出40.1%
25.9%
净利率更高
GPOR
高出95.3%
-62.0%
两年增速更快
RARE
近两年复合增速
18.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $398.2M | $207.3M |
| 净利润 | $132.4M | $-128.6M |
| 毛利率 | 76.6% | — |
| 营业利润率 | 44.9% | -54.7% |
| 净利率 | 33.3% | -62.0% |
| 营收同比 | 66.0% | 25.9% |
| 净利润同比 | 148.5% | 3.5% |
| 每股收益(稀释后) | $7.98 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GPOR
RARE
| Q4 25 | $398.2M | $207.3M | ||
| Q3 25 | $379.7M | $159.9M | ||
| Q2 25 | $447.6M | $166.5M | ||
| Q1 25 | $197.0M | $139.3M | ||
| Q4 24 | $239.9M | $164.6M | ||
| Q3 24 | $253.9M | $139.5M | ||
| Q2 24 | $181.1M | $147.0M | ||
| Q1 24 | $283.2M | $108.8M |
净利润
GPOR
RARE
| Q4 25 | $132.4M | $-128.6M | ||
| Q3 25 | $111.4M | $-180.4M | ||
| Q2 25 | $184.5M | $-115.0M | ||
| Q1 25 | $-464.0K | $-151.1M | ||
| Q4 24 | $-273.2M | $-133.2M | ||
| Q3 24 | $-14.0M | $-133.5M | ||
| Q2 24 | $-26.2M | $-131.6M | ||
| Q1 24 | $52.0M | $-170.7M |
毛利率
GPOR
RARE
| Q4 25 | 76.6% | — | ||
| Q3 25 | 74.6% | — | ||
| Q2 25 | 80.7% | — | ||
| Q1 25 | 57.9% | — | ||
| Q4 24 | 63.2% | — | ||
| Q3 24 | 64.6% | — | ||
| Q2 24 | 52.2% | — | ||
| Q1 24 | 69.4% | — |
营业利润率
GPOR
RARE
| Q4 25 | 44.9% | -54.7% | ||
| Q3 25 | 41.9% | -106.9% | ||
| Q2 25 | 56.0% | -64.8% | ||
| Q1 25 | 6.1% | -102.6% | ||
| Q4 24 | -131.3% | -74.3% | ||
| Q3 24 | 5.7% | -94.6% | ||
| Q2 24 | -10.0% | -79.1% | ||
| Q1 24 | 28.9% | -151.9% |
净利率
GPOR
RARE
| Q4 25 | 33.3% | -62.0% | ||
| Q3 25 | 29.3% | -112.8% | ||
| Q2 25 | 41.2% | -69.0% | ||
| Q1 25 | -0.2% | -108.5% | ||
| Q4 24 | -113.9% | -80.9% | ||
| Q3 24 | -5.5% | -95.7% | ||
| Q2 24 | -14.5% | -89.5% | ||
| Q1 24 | 18.4% | -156.8% |
每股收益(稀释后)
GPOR
RARE
| Q4 25 | $7.98 | $-1.28 | ||
| Q3 25 | $4.45 | $-1.81 | ||
| Q2 25 | $9.12 | $-1.17 | ||
| Q1 25 | $-0.07 | $-1.57 | ||
| Q4 24 | $-14.72 | $-1.34 | ||
| Q3 24 | $-0.83 | $-1.40 | ||
| Q2 24 | $-1.51 | $-1.52 | ||
| Q1 24 | $2.34 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.8M | $421.0M |
| 总债务越低越好 | $788.2M | — |
| 股东权益账面价值 | $1.8B | $-80.0M |
| 总资产 | $3.0B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势,按日历期对齐
现金及短期投资
GPOR
RARE
| Q4 25 | $1.8M | $421.0M | ||
| Q3 25 | $3.4M | $202.5M | ||
| Q2 25 | $3.8M | $176.3M | ||
| Q1 25 | $5.3M | $127.1M | ||
| Q4 24 | $1.5M | $174.0M | ||
| Q3 24 | $3.2M | $150.6M | ||
| Q2 24 | $1.2M | $480.7M | ||
| Q1 24 | $8.2M | $112.3M |
总债务
GPOR
RARE
| Q4 25 | $788.2M | — | ||
| Q3 25 | $691.7M | — | ||
| Q2 25 | $695.2M | — | ||
| Q1 25 | $700.4M | — | ||
| Q4 24 | $702.9M | — | ||
| Q3 24 | $694.4M | — | ||
| Q2 24 | $679.5M | — | ||
| Q1 24 | $636.4M | — |
股东权益
GPOR
RARE
| Q4 25 | $1.8B | $-80.0M | ||
| Q3 25 | $1.8B | $9.2M | ||
| Q2 25 | $1.8B | $151.3M | ||
| Q1 25 | $1.7B | $144.2M | ||
| Q4 24 | $1.7B | $255.0M | ||
| Q3 24 | $2.1B | $346.8M | ||
| Q2 24 | $2.1B | $432.4M | ||
| Q1 24 | $2.2B | $140.3M |
总资产
GPOR
RARE
| Q4 25 | $3.0B | $1.5B | ||
| Q3 25 | $2.9B | $1.2B | ||
| Q2 25 | $3.0B | $1.3B | ||
| Q1 25 | $2.9B | $1.3B | ||
| Q4 24 | $2.9B | $1.5B | ||
| Q3 24 | $3.2B | $1.5B | ||
| Q2 24 | $3.2B | $1.6B | ||
| Q1 24 | $3.3B | $1.3B |
负债/权益比
GPOR
RARE
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.39× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $185.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势,按日历期对齐
经营现金流
GPOR
RARE
| Q4 25 | $185.4M | $-99.8M | ||
| Q3 25 | $209.1M | $-91.4M | ||
| Q2 25 | $231.4M | $-108.3M | ||
| Q1 25 | $177.3M | $-166.5M | ||
| Q4 24 | $148.8M | $-79.3M | ||
| Q3 24 | $189.7M | $-67.0M | ||
| Q2 24 | $123.5M | $-77.0M | ||
| Q1 24 | $188.0M | $-190.7M |
自由现金流
GPOR
RARE
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
自由现金流率
GPOR
RARE
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
资本支出强度
GPOR
RARE
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
现金转化率
GPOR
RARE
| Q4 25 | 1.40× | — | ||
| Q3 25 | 1.88× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GPOR
| Natural Gas Production | $296.9M | 75% |
| Other | $42.7M | 11% |
| Naturalgasliquidsales | $35.2M | 9% |
| Oil And Condensate | $23.4M | 6% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |